ASPYRE a novel genomic assay (IMAGE) Dowling & Dennis PR Caption Biofidelity CMO Dr. Wendy Levin says the company has developed a novel genomic assay that can analyze DNA and RNA concurrently for NSCLC. Credit Biofidelity Usage Restrictions N/A License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.